Ticker brief · 2026-10-18

OSCR OSCAR HEALTH INC - CLASS A

OSCR bulls dominate, but cold hands weaken the breakout consensus

Consumer, Non-cyclical · Healthcare-Services

Lean: bullish
last close
$30.99
1 day
-7.0%
14 days
-7.1%
mkt cap
$9.7B
signals 14d
86
authors 14d
50
crowd 14d
-0.3σfade

OSCR sentiment is bullish, but demonstrated trading skill does not confirm the crowd: several prominent bulls have negative last-20-bets scores. The late-week shift is stronger technical confirmation through higher lows, an EMA bounce and relative strength, rather than a fresh business catalyst; UBS's earlier $36 target increase from $26 retained Neutral. Shares and LEAPS disclosures suggest sustained upside exposure, while a $45 partial-profit plan and failed-rally warnings argue for staged exits; the systematic book has no current position and its recorded LONG returned -0.66%.

BULL CAMP6 claims

Bulls expect reclaimed support, a two-month base and persistent relative strength to extend the advance. Growth, guidance raises and earnings beats supply the business argument, while Wave 3 forecasts point toward $45.41.

Key voices
@TheLongInvestMEDIUM-HIGHC-3.48@StockChaser_MEDIUMC+0.58@BullTradeFinderMEDIUM-HIGHC-2.41@BourbonCapMEDIUM-HIGHB-1.57@GnT_TradesMEDIUM-HIGHC-2.29
“Relative strength following a support bounce puts OSCR near a trendline breakout test.”— @StockChaser_ ·
BEAR / SKEPTIC1 claim

The bearish case is technical: a rising wedge could break down, and rallies have failed to hold. There is no developed bearish business thesis in the supplied activity.

Key voices
@EchoAnalysisMEDIUMC-0.85
“A rising-wedge breakdown threatens downside, making chasing the advance unattractive.”— @EchoAnalysis ·
Hypotheses9direction · basis · magnitude · supporters — NEW = first seen this week
▲OSCR's reclaimed support, higher lows, two-month base and relative strength favor a bullish breakout and continued near-term price appreciation.
bulltechnicalmedium if true~10d horizon-7.1% since 2026-10-09
@chad_venturesMEDIUMC-0.921s@StockChaser_MEDIUMC+0.582s@LeaderInvestsLOW-MEDIUMC-3.641s@GnT_TradesMEDIUM-HIGHC-2.291s@ChartWaveInvest-0.291s@ThePupOfWallStMEDIUM-HIGHC-1.471s+2 more
▲OSCR remains in a strong Elliott Wave 3 advance, with a long-term projection of $45.41 despite its substantial preceding rally.
bulltechnicallarge if true~40d horizonNEWthin⚠ single-author-7.1% since 2026-10-11
@TheLongInvestMEDIUM-HIGHC-3.482s@AsafNaamaniLOW-MEDIUMC-2.381s
▲OSCR's growth, guidance increases and earnings beats justify further share-price appreciation, supporting continued bullish exposure on improving business performance.
bullfundamentalmedium if true~30d horizonNEWthin⚠ single-author-8.3% since 2026-10-13
@Blue_1Trades+1.371s
▲OSCR's recovery from a severe drawdown represents a durable turnaround opportunity, supporting long-term accumulation and continued ownership after substantial appreciation.
bullfundamentalmedium if true~40d horizonNEW-7.1% since 2026-10-11
@StockChaser_MEDIUMC+0.581s@BullTradeFinderMEDIUM-HIGHC-2.412s@BourbonCapMEDIUM-HIGHB-1.571s · insight@MollySOSheaLOW-MEDIUMC+0.291s@TheLongInvestMEDIUM-HIGHC-3.481s
▲UBS's increase in Oscar Health's price target to $36 from $26 provides positive analyst support while its Neutral rating remains unchanged.
bullcatalystsmall if true~5d horizonNEWthin⚠ single-author-8.9% since 2026-10-12
@AIStockSavvyMEDIUMC-1.051s
▼OSCR's rising wedge and inability to sustain rallies signal near-term downside risk, making pursuit of the recent advance unattractive.
beartechnicalmedium if true~10d horizonNEWthin⚠ single-author-8.9% since 2026-10-12
@EchoAnalysisMEDIUMC-0.851s@Blue_1Trades+1.371s
◆Reaching $45 should trigger partial OSCR profit-taking while retaining remaining shares for long-term exposure, rather than a complete position exit.
neutralpositioningsmall if true~20d horizonthin⚠ single-author-7.1% since 2026-10-10
@Arturraposo1RLOW-MEDIUMB-1.121s
◆A standalone OSCR forecast projects a 235% rise from its base, expressing exceptional upside conviction without supplying a supporting business mechanism.
flagtechnicalextreme if true~10d horizonNEWthin⚠ single-author-8.9% since 2026-10-12
@TheProfInvestorMEDIUM-HIGHC-1.721s
▲OSCR belongs within a long-term AI-healthcare investment thesis spanning public and private companies, supporting exposure to technology-driven healthcare business opportunities.
bullfundamentalmedium if true~40d horizonNEWthin⚠ single-author-9.7% since 2026-10-14
@MollySOSheaLOW-MEDIUMC+0.291s
Direct calls3authors taking explicit directional positions
@BullTradeFinderMEDIUM-HIGHC-2.41
Buy OSCR for the long term; the supplied rationale mentions price objectives without providing an OSCR target.
@Arturraposo1RLOW-MEDIUMB-1.12
Take partial profits at $45 and retain the remaining shares for the long term.
@BearlovesbullMEDIUMC-0.26
Discloses an existing OSCR position alongside new purchases and expresses a bullish December horizon.
Sellside activity1
UBS pt_raise PT 36 (from 26)Maintains Neutral while increasing the price target.
via @AIStockSavvy
News / data points5discrete events + data quoted by authors
@AIStockSavvyMEDIUMC-1.05
UBS maintains Neutral while raising its Oscar Health target to $36 from $26.
2026-10-12-8.9% since
@LeaderInvestsLOW-MEDIUMC-3.64
Higher lows and an EMA bounce create a potential OSCR breakout setup.
2026-10-15-7.4% since
@AsafNaamaniLOW-MEDIUMC-2.38
A long-term Wave 3 projection targets $45.41 following a 212% advance.
2026-10-11-7.1% since
@GnT_TradesMEDIUM-HIGHC-2.29
OSCR's two-month base stands out among bullish healthcare setups.
2026-10-11-7.1% since
@ThePupOfWallStMEDIUM-HIGHC-1.47
OSCR strength coincides with healthcare sector outperformance.
2026-10-14-9.7% since
Position disclosures3skin in the game
@TheLongInvestMEDIUM-HIGHC-3.48
Accumulated OSCR over 18 months at $12-$14 and maintains conviction.
@TheRonnieVShowMEDIUM-HIGHC-2.45
Continues to hold OSCR shares and LEAPS.
@StockChaser_MEDIUMC+0.58
OSCR is a major holding, with gains from an entry below 15.
Desk readconvergence assessment
Convergence is strongest around technical continuation; fundamental support is thinner, and the disagreement concerns breakout durability versus a rising-wedge failure. Bulls have more MEDIUM-HIGH voices than bears, but TheLongInvest (-2.88), BullTradeFinder (-2.41) and GnT_Trades (-2.29) have cold last-20-bets records; the only HIGH-credibility author, cantonmeow (2.74), reacts negatively without supplying an actionable chart condition. Confirmed breakout follow-through and fresh operating evidence would strengthen the case, while failed support would favor the bear thesis; the recorded book LONG returned -0.66%, and prior hypotheses remain unscored, providing no realized validation of the bullish consensus.
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d71% mid · 31 pctile own 1yIV/HV 1.34×
Skew — 25Δ RR 30d-0.078 5 pctile own 1yputs bid vs calls (downside bid)
Net dealer OI (NDOI)+7.95 elevated5-session Δ +0.45 (as of 2026-07-06)
OI alarmquietlast alarm 2026-02-10 (z=2.5)
Crowd statevictory-lap fade activeflagged 2026-07-01 (MC3f / MC3L exhaustion)
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now +0.40 (−1 bearish … +1 bullish)
Who spoke50
authorgradetrader scoresignalsmean sent
@TheLongInvestC-3.4814+0.47
@StockChaser_C+0.586+0.60
@Blue_1Trades·+1.374+0.39
@LeaderInvestsC-3.644+0.20
@Arturraposo1RB-1.122+0.60
@Ashton_1nvestsB+0.252+0.38
@Fibonacci_TAC-0.922+0.12
@chad_venturesC-0.922+0.45
@AlexMarenco1C-1.182+0.10
@dannycheng2022C-2.642+0.55
@TheValueTradeC+0.352+0.50
@ChartWaveInvest·-0.292+0.25
@TheRonnieVShowC-2.452+0.50
@MMatters22596C-0.732+0.25
@BullTradeFinderC-2.412+0.72
@MollySOSheaC+0.292+0.42
@tradealgo_C+1.911+0.70
@TheMarket_MonkC-1.511+0.60
@cialuTradingC-1.671+0.70
@Sir_KoryC-2.141+0.40
@DrStoxxC+0.181+0.55
@StockSwingAlertC-1.171+0.30
@TinyToothDDSC-0.961+0.75
@stageanalysisC-1.401+0.00
@HejToJeMaraB+0.751+0.15
Recent signals30of 86 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@Bearlovesbull+0.45Bought DRAM, SOXL and LEN; expects gains by December and will review NVO and HIMS Monday. — Discloses new purchases, an existing OSCR position and a bullish December horizon.-2.8%
2026-10-16@TheLongInvest+0.25Projects ADUR to 36 after a held triple bottom and cites OSCR as a comparable pattern.-2.8%
2026-10-16@TheLongInvest+0.45Discloses adding a basket of companies due partly to confidence in management.-2.8%
2026-10-16@TheLongInvest+0.45Reports ZETA's premarket rebound and says ZETA and OSCR remain in strong Wave 3 trends.-2.8%
2026-10-15@ClassicRoy+0.65Provides long-term bullish price targets for multiple stocks; output capped at six.-7.4%
2026-10-15@TheStockerMan+0.30Reaffirms a long-term SOFI holding, contrasts it with a completed RKLB swing, and cites OSCR as precedent.-7.4%
2026-10-15@LeaderInvests+0.35OSCR is stair-stepping higher lows and could break out after an EMA bounce.-7.4%
2026-10-15@TheValueTrade+0.25Recaps portfolio winners, a WYFI loss, and a 60% year-to-date return while emphasizing risk management.-7.4%
2026-10-15@LeaderInvests-0.20A daily watchlist accompanied by a broad warning that markets look rough.-7.4%
2026-10-15@StockChaser_+0.75Discloses OSCR as a major holding and celebrates its relative strength and gains from below 15.-7.4%
2026-10-14@ChartWaveInvest+0.30Notes OSCR is showing relative strength during the session.-9.7%
2026-10-14@MollySOShea+0.50Frames Oscar Health's recovery from a 95% drawdown to a roughly $10B company as a turnaround.-9.7%
2026-10-14@ThePupOfWallSt+0.30Highlights OSCR strength alongside healthcare sector outperformance.-9.7%
2026-10-14@MollySOShea+0.35Presents Thrive's long-term AI-healthcare investment thesis across public and private companies.-9.7%
2026-10-14@Ruby_investment+0.48Notes OSCR is up 136% year to date despite receiving little attention and discloses no position.-9.7%
2026-10-14@TheRonnieVShow+0.35Claims a proprietary DCA optimizer outperformed normal dollar-cost averaging over one year.-9.7%
2026-10-14@BullTradeFinder+0.65Frames five growth stocks as successors to past major winners after severe drawdowns.-9.7%
2026-10-13@BullTradeFinder+0.80Buy APP, NFLX, ZETA, OSCR and FICO for the long term. — Explicitly identifies five long-term purchases and gives price objectives for each.-8.3%
2026-10-13@BourbonCap+0.55Presents six volatile Google-linked or 13F holdings as recovering or attractive long-term opportunities.-8.3%
2026-10-13@TheLongInvest+0.65Says both stocks retain strong upside momentum within Elliott Wave 3.-8.3%
2026-10-13@Blue_1Trades+0.70Discloses a financial interest while arguing OSCR should rise on growth, guidance raises and earnings beats.-8.3%
2026-10-13@spacemnke+0.00Morning watchlist provides trigger levels without explicit entry intent.-8.3%
2026-10-13@gabz_investing+0.00Healthcare chart highlights UNH selling pressure below a long-term average and gives support/resistance.-8.3%
2026-10-13@oratnek_ill+0.10Daily watchlist identifies pivot and volume setups without explicit entry intent.-8.3%
2026-10-12@StockChaser_+0.45Notes relative strength after a support bounce and an approaching trendline breakout test.-8.9%
2026-10-12@EchoAnalysis-0.70Warns against chasing and expects a breakdown from a rising wedge.-8.9%
2026-10-12@StockChaser_+0.35Uses prior winners to support a highly bullish $30 forecast for ONDS.-8.9%
2026-10-12@MMatters22596+0.50Promotes realized historical gains while claiming unnamed new holdings can double.-8.9%
2026-10-12@Blue_1Trades-0.35Reports closing OSCR calls because the stock cannot hold rallies.-8.9%
2026-10-12@TheProfInvestor+0.85Expresses strong conviction that OSCR will rise 235% from its base.-8.9%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.